title: Low-dose cyclosporine and antithymocyte globulin improve renal allograft survival in highly sensitized patients.
authors.affiliation: Dulwich Hospital Renal Unit, London, England.
authors.forename: A
authors.initials: A
authors.lastname: Palmer
authors.forename: M
authors.initials: M
authors.lastname: Bewick
authors.forename: K
authors.initials: K
authors.lastname: Welsh
authors.forename: S
authors.initials: S
authors.lastname: Snowden
authors.forename: V
authors.initials: V
authors.lastname: Parsons
authors.forename: D
authors.initials: D
authors.lastname: Taube
mesh_terms: D000961:Antilymphocyte Serum / Q000008:administration & dosage*; D002102:Cadaver; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000008:administration & dosage* / Q000097:blood; D004305:Dose-Response Relationship, Drug; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation; D011239:Prednisolone / Q000008:administration & dosage; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D000961:Antilymphocyte Serum; D003524:Cyclosporins; D011239:Prednisolone; D003404:Creatinine